Targeting HMGCS1 in combination with fluvastatin is attractive in tumor cells where HMGCS1 is robustly upregulated in response to statin treatment as was the case in the lung and breast cancer cell lines used in our study. The gene discussed is HMGCS1; the disease is breast cancer.